2 completed, 2 recruiting. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Recruiting 2 |
| Phase 2 | 3 | Recruiting 2, Completed 1 |
Follow Leukemia, Acute Lymphoblastic: new trials by email Literature Review of Leukemia, Acute Lymphoblastic trials Research Report on Leukemia, Acute Lymphoblastic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias Autologous HuCD19 ( Anti-CD19)CAR T cells, Cyclophosphamide, Fludarabine - Leukemia, Lymphocytic, Chronic, B-Cell, B-Lymphocytic Leukemia, Chronic | Phase 1 / Phase 2 | Recruiting | National Cancer Institute (NCI) | 132 | 2024-09-03 | 2026-10-16 |
| CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma CART-19 - Leukemia, Acute Lymphoblastic, Lymphoma, Non-Hodgkin | Phase 1 / Phase 2 | Recruiting | University of Sao Paulo | 81 | 2024-03-21 | 2024-12-09 |
| Safety of Expanded Haploidentical Natural Killer Cells for Leukemia Expanded Haploidentical Natural Killer cells, IL-2 - Leukemia, Acute Myeloid, Leukemia, Acute Lymphoblastic | Phase 1 | Completed | Belarusian Research Center for Pediatric Oncology, Hematology and Immunology | 10 | 2019-01-02 | 2022-03-02 |
| GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia Allogeneic stem cell transplantation, Fludarabine monophosphate, Busulfan - Leukemia, Acute Lymphoblastic, Acute Myeloid Leukemia | Phase 1 / Phase 2 | Completed | St. Petersburg State Pavlov Medical University | 27 | 2016-06-01 | 2020-11-23 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (4) · Leukemia, Myeloid, Acute (2) · Immune System Diseases (1) · Leukemia, Biphenotypic, Acute (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1)
Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Immunoproliferative Disorders (4) · Leukemia (4) · Leukemia, Lymphoid (4) · Lymphatic Diseases (4) · Lymphoproliferative Disorders (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Immune System Diseases (3) · Leukemia, Myeloid (2) · Chronic Disease (1) · Disease Attributes (1) · Leukemia, B-Cell (1) · Pathologic Processes (1)
Bendamustine Hydrochloride (1) · Busulfan (1) · CTL019 chimeric antigen receptor (1) · Cyclophosphamide (1) · Interleukin-2 (1) · Rituximab (1) · fludarabine (1) · fludarabine phosphate (1)
Belarusian Research Center for Pediatric Oncology, Hematology and Immunology (1) · National Cancer Institute (NCI) (1) · St. Petersburg State Pavlov Medical University (1) · University of Sao Paulo (1)
Belarus (1) · Brazil (1) · Russia (1) · United States (1)
Boris V. Afanasyev, Professor (1) · Diego V Cle, MD, PhD, MBA (1) · James N Kochenderfer, M.D. (1) · Olga Aleinikova (1)